These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 28628281)
1. Genomic analysis of melanoma evolution following a 30-year disease-free interval. Miller JJ; Lofgren KA; Hughes SR; Cash SE; Kenny PA J Cutan Pathol; 2017 Sep; 44(9):805-808. PubMed ID: 28628281 [TBL] [Abstract][Full Text] [Related]
2. Clonal persistence and evolution during a decade of recurrent melanoma. Wang E; Voiculescu S; Le Poole IC; El-Gamil M; Li X; Sabatino M; Robbins PF; Nickoloff BJ; Marincola FM J Invest Dermatol; 2006 Jun; 126(6):1372-7. PubMed ID: 16470173 [TBL] [Abstract][Full Text] [Related]
3. Melanoma arising in a large plaque-type blue nevus with subcutaneous cellular nodules. Yeh I; Fang Y; Busam KJ Am J Surg Pathol; 2012 Aug; 36(8):1258-63. PubMed ID: 22790865 [TBL] [Abstract][Full Text] [Related]
4. Late recurrence of malignant melanoma and second primary malignant melanoma: a report of 3 patients. Yoshitatsu S; Hosokawa K; Kakibuchi M; Nishimoto S; Itami S Ann Plast Surg; 1997 Jun; 38(6):663-4. PubMed ID: 9188987 [No Abstract] [Full Text] [Related]
5. Analysis of KIT expression and gene mutation in human acral melanoma: with a comparison between primary tumors and corresponding metastases/recurrences. Dai B; Cai X; Kong YY; Yang F; Shen XX; Wang LW; Kong JC Hum Pathol; 2013 Aug; 44(8):1472-8. PubMed ID: 23528861 [TBL] [Abstract][Full Text] [Related]
6. Two cutaneous malignant melanomas at the same anatomic site: a case report with molecular evaluation. Edinger JT; Radfar A; Jukic DM J Cutan Pathol; 2009 Oct; 36 Suppl 1():74-9. PubMed ID: 19281486 [TBL] [Abstract][Full Text] [Related]
8. [Verrucous malignant melanoma (spontaneous regression and simultaneous development of a secondary tumor)]. Mahrle C; Bolling R; Gartmann H Z Hautkr; 1977 Sep; 52(17):897-905. PubMed ID: 910537 [TBL] [Abstract][Full Text] [Related]
9. Ultra-late recurrence of malignant melanoma after a disease-free interval of 41 years. Terhorst D; Radke C; Trefzer U Clin Exp Dermatol; 2010 Apr; 35(3):e20-1. PubMed ID: 20500162 [No Abstract] [Full Text] [Related]
10. [Multiple primary melanomas of the hair follicles--a special form of malignant melanoma of the skin]. Sigg C; Pelloni F; Hardmeier T Hautarzt; 1988 Jul; 39(7):447-51. PubMed ID: 3220759 [TBL] [Abstract][Full Text] [Related]
11. Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma. Soufir N; Lacapere JJ; Bertrand G; Matichard E; Meziani R; Mirebeau D; Descamps V; Gérard B; Archimbaud A; Ollivaud L; Bouscarat F; Baccard M; Lanternier G; Saïag P; Lebbé C; Basset-Seguin N; Crickx B; Cave H; Grandchamp B Br J Cancer; 2004 Jan; 90(2):503-9. PubMed ID: 14735200 [TBL] [Abstract][Full Text] [Related]
12. Circulating cell-free microRNAs in cutaneous melanoma staging and recurrence or survival prognosis. Polini B; Carpi S; Romanini A; Breschi MC; Nieri P; Podestà A Pigment Cell Melanoma Res; 2019 Jul; 32(4):486-499. PubMed ID: 30481404 [TBL] [Abstract][Full Text] [Related]
13. Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma Patient Outcome Prediction Tool with a 31-gene expression profile-based classification. Ferris LK; Farberg AS; Middlebrook B; Johnson CE; Lassen N; Oelschlager KM; Maetzold DJ; Cook RW; Rigel DS; Gerami P J Am Acad Dermatol; 2017 May; 76(5):818-825.e3. PubMed ID: 28110997 [TBL] [Abstract][Full Text] [Related]
15. Longitudinal study of recurrent metastatic melanoma cell lines underscores the individuality of cancer biology. Pos Z; Spivey TL; Liu H; Sommariva M; Chen J; Wunderlich JR; Parisi G; Tomei S; Ayotte BD; Stroncek DF; Malek JA; Robbins PF; Rivoltini L; Maio M; Chouchane L; Wang E; Marincola FM J Invest Dermatol; 2014 May; 134(5):1389-1396. PubMed ID: 24270663 [TBL] [Abstract][Full Text] [Related]
16. [Late recurrence of melanoma beyond 10 years]. Avril MF; Nguyen T; Duvillard P; Bognel C; Margulis A Ann Dermatol Venereol; 1994; 121(6-7):454-8. PubMed ID: 7702277 [TBL] [Abstract][Full Text] [Related]
17. Late recurrence of malignant melanoma: a report of five cases, a review of the literature and a study of associated factors. Levy E; Silverman MK; Vossaert KA; Kopf AW; Bart RS; Golomb FM; Levenstein MJ Melanoma Res; 1991; 1(1):63-7. PubMed ID: 1822771 [TBL] [Abstract][Full Text] [Related]
18. Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma. Demunter A; Stas M; Degreef H; De Wolf-Peeters C; van den Oord JJ J Invest Dermatol; 2001 Dec; 117(6):1483-9. PubMed ID: 11886512 [TBL] [Abstract][Full Text] [Related]
19. Cancer risks and survival in patients with multiple primary melanomas: Association with family history of melanoma and germline CDKN2A mutation status. Helgadottir H; Tuominen R; Olsson H; Hansson J; Höiom V J Am Acad Dermatol; 2017 Nov; 77(5):893-901. PubMed ID: 28818438 [TBL] [Abstract][Full Text] [Related]
20. Ultra-late recurrence of malignant melanoma after 40 years of quiescent disease. Saleh D; Peach AH J Surg Oncol; 2011 Mar; 103(3):290-1. PubMed ID: 21337559 [No Abstract] [Full Text] [Related] [Next] [New Search]